Network origin in Joe Principe first degree
Entity | Entity type | Industry | |
---|---|---|---|
Avara Pharmaceutical Services, Inc.
Avara Pharmaceutical Services, Inc. Pharmaceuticals: MajorHealth Technology Avara Pharmaceutical Services, Inc. is a contract development and manufacturing organization. It manufactures pharmaceutical products. It capabilities include primary and secondary manufacturing and packaging. It also offers cGMP production of APIs services. The company was founded in 1995 and is headquartered in Norwalk, CT.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Holding Company | Biotechnology | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Joe Principe via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Altimmune UK Ltd.
Altimmune UK Ltd. BiotechnologyHealth Technology Altimmune UK Ltd. engages in the discovery and development of prophylactic and therapeutic vaccines against mutating viruses and cancer. It provides T-cell vaccines to protect patients against infectious diseases (most notably mutating viruses) and to treat cancers; and Flunisyn, a DepoVaccine to protect against influenza. The company was founded by Bertrand Georges in 2003 and is headquartered in London, the United Kingdom. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Piramed Ltd.
Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The University of Manchester | College/University | Graduate Degree | |
Oxford Immunotec Ltd.
Oxford Immunotec Ltd. Medical SpecialtiesHealth Technology Oxford Immunotec Ltd. operates as a medical diagnostic company. It develops and sells medical diagnostic products. The company was founded by Peter Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom. | Medical Specialties | Corporate Officer/Principal | |
Abzena (Cambridge) Ltd.
Abzena (Cambridge) Ltd. Miscellaneous Commercial ServicesCommercial Services Abzena (Cambridge) Ltd. provides antibody engineering and immunogenicity screening services. The company was founded in 2004 and is headquartered in Babraham, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
PolyTherics Ltd.
PolyTherics Ltd. Pharmaceuticals: MajorHealth Technology PolyTherics Ltd. develops biomedical polymers for therapeutic applications. The company was founded by Antony Godwin, Sunil Shaunak and Steve Brocchini in 2001 and is headquartered in Babraham, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
HOSPIRA, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
Villanova University | College/University | Undergraduate Degree | |
SMITH & NEPHEW PLC | Medical Specialties | Chief Operating Officer | |
BIOVENTUS INC. | Medical Specialties | Director/Board Member | |
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Biotechnology | Chief Executive Officer | |
CastleVax, Inc.
CastleVax, Inc. BiotechnologyHealth Technology CastleVax, Inc. is an American vaccine platform company based on technology developed at the Icahn School of Medicine at Mount Sinai, headquartered in an undisclosed location. The private company's platform uses a disease virus to induce the human immune system to produce neutralizing antibodies targeted at a range of emerging and pandemic viruses, including SARS-CoV-2. The technology was developed in response to the growing need for vaccine independence and pandemic response preparedness. CastleVax's leading candidate, NDV-HXP-S, is currently being tested in clinical trials in multiple countries around the world. The company was founded by Florian Krammer, Peter Palese, Adolfo García-Sastre. | Biotechnology | Chief Executive Officer | |
Astro Bidco Ltd.
Astro Bidco Ltd. BiotechnologyHealth Technology Astro Bidco Ltd. is a British biopharmaceutical company founded in 2018 that specializes in integrated drug discovery, design, optimization, manufacturing, and chemistry services. | Biotechnology | Director/Board Member |
Statistics
International
United Kingdom | 9 |
United States | 7 |
Israel | 2 |
Sectoral
Health Technology | 11 |
Commercial Services | 3 |
Consumer Services | 3 |
Finance | 2 |
Operational
Director/Board Member | 9 |
Corporate Officer/Principal | 5 |
Chief Executive Officer | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Chief Operating Officer | 3 |
Most connected contacts
Insiders | |
---|---|
Campbell Bunce | 8 |
Matthew Stober | 8 |
Michelle Dawn Neaves | 3 |
Andy Glanville | 1 |
Patrick Hatem | 1 |
Deborah Graham | 1 |
Louise Duffy | 1 |
Larry Lee | 1 |
- Stock Market
- Insiders
- Joe Principe
- Company connections